SCHEMBL9317644

SCHEMBL9317644

CCC(O)[n+]1ccccc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 1/20 0.36
TSHR P16473 1/20 0.32
TRPA1 O75762 1/20 0.30
ABCB11 O95342 1/20 0.30
ESR1 P03372 1/20 0.30
PGR P06401 1/20 0.30
CHRM2 P08172 1/20 0.30
HTR1A P08908 1/20 0.30
ADRA2A P08913 1/20 0.30
ADORA3 P0DMS8 1/20 0.30
CHRM1 P11229 1/20 0.30
DRD1 P21728 1/20 0.30
TBXA2R P21731 1/20 0.30
ACHE P22303 1/20 0.30
PTGS1 P23219 1/20 0.30
SLC6A2 P23975 1/20 0.30
PDE4A P27815 1/20 0.30
SLC6A4 P31645 1/20 0.30
ADRA1A P35348 1/20 0.30
OPRM1 P35372 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Bromide SCHEMBL10537002 0.97 LMNA (0.34) LMNATSHRCHRM2ADRA2AADORA3
SCHEMBL16699576 0.85
SCHEMBL20534808 0.75 CHRM2 (0.42) LMNATSHRABCB11ESR1PGR
SCHEMBL16668997 0.74
SCHEMBL7048878 0.74 ABCB11 (0.30) ABCB11ESR1PGRCHRM2HTR1A
SCHEMBL30335921 0.73 CHRM2 (0.45) LMNATSHRABCB11ESR1PGR
Hydrochloric Acid SCHEMBL11442312 0.72 KMT2A (0.47) LMNATSHRABCB11ESR1PGR
Hydrochloric Acid SCHEMBL11436662 0.72 KMT2A (0.47) LMNATSHRABCB11ESR1PGR
SCHEMBL4128667 0.72 THRB (0.32)
SCHEMBL25364120 0.72 LMNA (0.31) LMNATRPA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 70 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US claimed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO claimed
US-10227274-B2 Separations with ionic liquid solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2019-03-12 US claimed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP claimed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US claimed
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY CHEVRON PHILLIPS CHEMICAL CO LP (US) 2026-01-15 US disclosed
US-12441671-B2 Metal-containing ionic liquids with reduced viscosity CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-10-14 US disclosed
US-12365647-B2 Method for preparing acrylonitrile dimer LG CHEM, LTD. (KR) 2025-07-22 US disclosed
US-20250196021-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP 2025-06-19 US disclosed
WO-2025128828-A1 METHODS OF SOLVENT DISPLACEMENT FOR METAL-CONTAINING IONIC LIQUIDS CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) 2025-06-19 WO disclosed
EP-3507346-B1 ALKYLATION OF REFINERY PENTENES WITH ISOBUTANE CHEVRON USA INC (US) 2025-04-30 EP disclosed
EP-3950667-B1 METHOD FOR PREPARING ACRYLONITRILE DIMER LG CHEMICAL LTD (KR) 2025-02-26 EP disclosed
EP-3244987-A1 SEPARATIONS WITH IONIC LIQUID SOLVENTS Chevron Phillips Chemical Company LP (US) 2017-11-22 EP disclosed
US-9822046-B1 Farnesane alkylation CHEVRON U.S.A. INC. (US) 2017-11-21 US disclosed
US-9802186-B2 Reactor for homogeneous regeneration of spent ionic liquid CHEVRON U.S.A. INC. (US) 2017-10-31 US disclosed
US-20170216827-A1 REGENERATION OF ACIDIC IONIC LIQUID WITHOUT ADDITION OF A HYDROGENATION CATALYST CHEVRON U.S.A. INC. 2017-08-03 US disclosed
WO-2017132016-A1 REGENERATION OF ACIDIC IONIC LIQUID WITHOUT ADDITION OF A HYDROGENATION CATALYST CHEVRON U.S.A. INC. (US) 2017-08-03 WO disclosed
US-20170216828-A1 REACTOR FOR HOMOGENEOUS REGENERATION OF SPENT IONIC LIQUID CHEVRON U.S.A. INC. 2017-08-03 US disclosed
US-20150133711-A1 Separations With Ionic Liquid Solvents CHEVRON PHILLIPS CHEMICAL COMPANY LP 2015-05-14 US disclosed
US-H1313-H From polyepichlorohydrin and alkali azides, quaternary ammonium catalysts MINNESOTA MINING AND MANUFACTURING COMPANY (US) 1994-05-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170216827-A1 REGENERATION OF ACIDIC IONIC LIQUID WITHOUT ADDITION OF A HYDROGENATION CATALYST MGMT, GIGYF2, PUF60 LMNA 4601/4885TSHR 3955/4885TRPA1 2284/4885
US-12365647-B2 Method for preparing acrylonitrile dimer ADH1C, ADH1A, PUF60 LMNA 1667/4885TSHR 2375/4885TRPA1 1507/4885
US-20260015304-A1 METAL-CONTAINING IONIC LIQUIDS WITH REDUCED VISCOSITY EXOC3, ELL, IGF2BP2 LMNA 537/4885TSHR 3205/4885TRPA1 2079/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.